Replimune plans layoffs as FDA rejects cancer drug

Replimune (REPL) stock plunges as the company seeks layoffs following the FDA rejection of its cancer drug RP1 for melanoma.

'Attempted to hide his crimes': Man repeatedly shot roommate in the face and then locked the victim's body in his own bedroom for several days

"The defendant attempted to hide his crimes and act as if nothing had changed, but he could not escape the truth." The post ...